Physician profile
Peter J Riga
NPI 1972589893
$1,679.54
in general payments reported to CMS, 2019-2025
9 companies · $53.15 in 2025
The $53.15 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $65.08 · 2021: $192 · 2022: $318 · 2023: $668 · 2024: $228 · 2025: $53.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $725.66 | 2022-2024 | Xarelto |
| Abbvie INC. | $491.70 | 2021-2025 | Dalvance |
| Penumbra, INC. | $144.67 | 2023-2024 | Indigo System |
| Cardiovascular Systems INC. | $112.08 | 2019 | |
| Allergan, INC. | $95.18 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $43.12 | 2024 | Xarelto |
| Inari Medical, INC. | $37.55 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $16.69 | 2021 | |
| Boston Scientific Corporation | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Riga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.